{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:31:29Z","timestamp":1776745889883,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41409-018-0132-6","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T09:39:32Z","timestamp":1527154772000},"page":"1428-1433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bloodless tandem autologous transplant in Jehovah\u2019s Witness patients"],"prefix":"10.1038","volume":"53","author":[{"given":"Rafiullah","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. S.","family":"Jethava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Tricot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"132_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tmrv.2003.12.004","volume":"18","author":"ZM Bodnaruk","year":"2004","unstructured":"Bodnaruk ZM, Wong CJ, Thomas MJ. Meeting the clinical challenge of chare for Jehovah\u2019s Witnesses. Transfus Med Rev. 2004;18:105\u201316.","journal-title":"Transfus Med Rev"},{"key":"132_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1548-5315(11)70948-2","volume":"3","author":"NM Brown","year":"2006","unstructured":"Brown NM, Matthews B, Ford PA. Treatment of a Jehovah\u2019s Witness using a transfusion-free autologous stem cell transplant protocol. Community Oncol. 2006;3:776\u201380.","journal-title":"Community Oncol"},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/sj.bmt.1705223","volume":"37","author":"S Cuirea","year":"2006","unstructured":"Cuirea S, Beri R, Dobogai L, Chunduri S, Mahmud N, Rondelli D, et al. The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products [letter]. Bone Marrow Transplant. 2006;37:325\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"132_CR4","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1200\/JCO.2004.01.144","volume":"22","author":"KK Ballen","year":"2005","unstructured":"Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA. Autologous stem-cell transplantation can be performed safely without the use of blood-product support. J Clin Oncol. 2005;22:4087\u201394.","journal-title":"J Clin Oncol"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3109\/10428194.2012.733879","volume":"54","author":"AM Ronchetti","year":"2013","unstructured":"Ronchetti AM, Isnard F, Buffet M, Coman T, Gorin NC, Coppo P, et al. Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents. Leuk Lymphoma. 2013;54:1117\u20139.","journal-title":"Leuk Lymphoma"},{"key":"132_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/OTT.S112423","volume":"10","author":"K Nadiminti","year":"2017","unstructured":"Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G. VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma. Onco Targets Ther. 2017;10:217\u201326.","journal-title":"Onco Targets Ther"},{"key":"132_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/sj.bmt.1703413","volume":"29","author":"P Frere","year":"2002","unstructured":"Frere P, Hermanne JP, Debouge MH, Fillet G, Beguin Y. Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant patients. Bone Marrow Transplant. 2002;29:589\u201394.","journal-title":"Bone Marrow Transplant"},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/qjmed\/hcm077","volume":"100","author":"CC Kariyawasan","year":"2007","unstructured":"Kariyawasan CC, Hughes DA, Jayatillake MM, Mehta AB. Multiple myeloma: causes and consequences of delay in diagnosis. QJM. 2007;100:635\u201340.","journal-title":"QJM"},{"key":"132_CR10","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/bjc.2011.450","volume":"105","author":"A Smith","year":"2011","unstructured":"Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105:1684\u201392.","journal-title":"Br J Cancer"},{"key":"132_CR11","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa032290","volume":"349","author":"M Attal","year":"2003","unstructured":"Attal M, Horousseau J, Facon T, Guilhot F, Doyen C, Fuzibet J, et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med. 2003;349:2495\u2013502.","journal-title":"N Engl J Med"},{"key":"132_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/asheducation-2016.1.485","volume":"494","author":"A Dispenzieri","year":"2016","unstructured":"Dispenzieri A. Myeloma: management of the newly diagnosed high-risk patient. Hematology. 2016;494:485\u201394.","journal-title":"Hematology"},{"key":"132_CR13","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1182\/blood-2014-07-552059","volume":"124","author":"B Barlogie","year":"2014","unstructured":"Barlogie B, Mitchell A, van Rhee F, Epstein J, Morgan GJ, Crowley J. Curing myeloma at last: defining criteria and providing the evidence. Blood. 2014;124:3043\u201351.","journal-title":"Blood"},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/j.1537-2995.2006.00947.x","volume":"46","author":"DM Rogers","year":"2006","unstructured":"Rogers DM, Crookston KP. The approach to the patient who refuses blood transfusion. Transfusion. 2006;46:1471\u20137.","journal-title":"Transfusion"},{"key":"132_CR15","first-page":"229","volume":"43","author":"MH Rodriquez","year":"2005","unstructured":"Rodriquez MH. [Bloodless medicine (article in Spanish)]. Rev Med Inst Mex Sequro Soc. 2005;43:229\u201335.","journal-title":"Rev Med Inst Mex Sequro Soc"},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/msj.21290","volume":"79","author":"A Shander","year":"2012","unstructured":"Shander A, Javidrooz M, Perelman S, Puzio T, Lobel G. From bloodless surgery to patient blood management. Mt Sinai J Med. 2012;79:56\u201365.","journal-title":"Mt Sinai J Med"},{"issue":"10 pt 2","key":"132_CR17","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1111\/trf.12752","volume":"54","author":"SM Frank","year":"2014","unstructured":"Frank SM, Wick SC, Dezern AE, Ness PM, Wasey JO, Pippa AC, et al. Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. Transfusion. 2014;54 (10 pt 2):2668\u201377.","journal-title":"Transfusion"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/01.sla.0000133352.25163.fd","volume":"240","author":"N Jabbour","year":"2004","unstructured":"Jabbour N, Gagandeep S, Mateo R, Sher L, Strum E, Donovan J, et al. Live donor liver transplantation without blood products: strategies developed for Jehovah\u2019s Witnesses offer broad application. Ann Surg. 2004;240:350\u20137.","journal-title":"Ann Surg"},{"key":"132_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2005.04.006","volume":"201","author":"N Jabbour","year":"2005","unstructured":"Jabbour N, Gagandeep S, Meteo R, Sher L, Genyk Y, Selby R. Transfusion free surgery: single institution experience of 27 consecutive liver transplants in Jehovah\u2019s Witnesses. J Am Coll Surg. 2005;201:412\u20137.","journal-title":"J Am Coll Surg"},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.transproceed.2004.02.045","volume":"36","author":"U Boggi","year":"2004","unstructured":"Boggi U, Vistoli F, Del Chiaro M, Croce C, Signori S, Marchetti P, et al. Kidney and pancreas transplants in Jehovah\u2019s witnesses: ethical and practical implications. Transplant Proc. 2004;36:601\u20132.","journal-title":"Transplant Proc"},{"key":"132_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.0902-4441.2003.00211.x","volume":"72","author":"D Laszio","year":"2004","unstructured":"Laszio D, Agazzi A, Goldhirsch A, Cinieri S, Bertolini F, Rabascio C, et al. Tailored therapy of adult acute leukaemia in Jehovah\u2019s Witnesses: unjustified reluctance to treat. Eur J Haematol. 2004;72:264\u20137.","journal-title":"Eur J Haematol"},{"key":"132_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/bmt.2009.43","volume":"44","author":"NM Brown","year":"2009","unstructured":"Brown NM, Kim SY, Ford PA. Autologous stem cell transplants in Jehovah\u2019s Witnesses [letter]. Bone Marrow Transplant. 2009;44:391\u20132.","journal-title":"Bone Marrow Transplant"},{"key":"132_CR23","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1200\/JCO.2014.57.9912","volume":"33","author":"PA Ford","year":"2015","unstructured":"Ford PA, Grant SJ, Mick R, Keck G. Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah\u2019s Witnesses. J Clin Oncol. 2015;33:1674\u20139.","journal-title":"J Clin Oncol"},{"key":"132_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12185-008-0055-x","volume":"87","author":"S Schmitt","year":"2008","unstructured":"Schmitt S, Mailaender V, Egerer G, Leo A, Becker S, Reinhardt P, et al. Successful autologous peripheral blood stem cell transplantation in a Jehovah\u2019s Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products. Int J Hematol. 2008;87:289\u201397.","journal-title":"Int J Hematol"},{"key":"132_CR25","first-page":"1292","volume":"90","author":"H Wandt","year":"2005","unstructured":"Wandt H, Schaefer-Eckhart K, Wilhelm M. Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support. Haematologica. 2005;90:1292\u20134.","journal-title":"Haematologica"},{"key":"132_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1704121","volume":"32","author":"T Zanz","year":"2003","unstructured":"Zanz T, Dohner H, Bunies D. Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah\u2019s Witness. Bone Marrow Transplant. 2003;32:437\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"132_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.bmt.1704179","volume":"32","author":"P Mazza","year":"2003","unstructured":"Mazza P, Prudenzana A, Amurri B, Palazzo G, Pisapia G, Stani L, et al. Myeloablative therapy and bone marrow transplantation in Jehovah\u2019s Witnesses with malignancies: single center experience. Bone Marrow Transplant. 2003;32:433\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"132_CR28","unstructured":"Winslow RM. New frontiers in transfusion medicine. American Association of Blood Banks Teleconference 1995."},{"key":"132_CR29","first-page":"6","volume":"8","author":"Biopure Hemopure.","year":"2003","unstructured":"Biopure Hemopure. Pharmaceutical approval monthly. F-D-C Rep. 2003;8:6.","journal-title":"F-D-C Rep"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0132-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:38Z","timestamp":1684617098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0132-6","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"17 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}